Stock Price Quote

PARMAX PHARMA LTD.

NSE : NABSE : 540359ISIN CODE : INE240T01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE29.300.18 (+0.62 %)
PREV CLOSE ( ) 29.12
OPEN PRICE ( ) 29.42
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9
TODAY'S LOW / HIGH ( )29.30 29.42
52 WK LOW / HIGH ( ) 24.1836.58
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-11 1994
Management Info
- Chairman Umang A Gosalia - Managing Director
Registered Office

Address Plot No. 20, Survey No. 52,8 B - Rajkot - Gondal National Highway No 27,Hadamtala, Tal. Kotda Sangani,
Rajkot,
Gujarat-360311

Phone 02827–270534 / 270535

Email info@parmaxpharma.com

Website www.parmaxpharma.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, Ahmedabad

NEWS

30Oct Parmax Pharma informs about certificate
Parmax Pharma has informed that it enclosed a Certificate dated 3rd Octo..
17Jun Parmax Pharma informs about details of
Parmax Pharma has informed about intimation regarding loss of share cert..
17Jun Parmax Pharma informs about details of
Parmax Pharma has informed about intimation regarding loss of share cert..
06Jun Parmax Pharma informs about loss of sh
Parmax Pharma has informed regarding loss of share certificate under Reg..
06Jun Parmax Pharma informs about loss of sh
Parmax Pharma has informed regarding loss of share certificate under Reg..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-17.53-1.05000000000002
Gross Profit -17.53 0.449999999999978
Operating Profit -11.4322.93
Net Sales 13.27154.24

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2621.00 (5.75%)
M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE)
peergroup  2079.80 (7.06%)
M.Cap ( in Cr)35233.07
TTK Healthcare (BSE)
peergroup  1591.35 (5.77%)
M.Cap ( in Cr)2248.63
Cipla (BSE)
peergroup  1398.80 (3.79%)
M.Cap ( in Cr)112938.41
Torrent Pharma (BSE)
peergroup  2685.00 (1.85%)
M.Cap ( in Cr)90872.60

Shareholding Pattern

NON-INSTITUTION 69.17%
PROMOTERS 30.83%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Parmax Pharma Ltd.

Parmax Pharma Ltd. was incorporated in the year 1994. Its today's share price is 29.3. Its current market capitalisation stands at Rs 10.96 Cr. In the latest quarter, company has reported Gross Sales of Rs. 154.24 Cr and Total Income of Rs.154.41 Cr. The company's management includes Ami R Shah, Nikhil Uchat, Umang A Gosalia.

It is listed on the BSE with a BSE Code of 540359 , NSE with an NSE Symbol of and ISIN of INE240T01014. It's Registered office is at Plot No. 20, Survey No. 52,8 B - Rajkot - Gondal National Highway No 27,Hadamtala, Tal. Kotda SanganiRajkot-360311, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BA Shah Associates, BA Shah SR Mehta & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.